by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Riley Nolan | Jun 10, 2022 | Featured, News
PROVIDENCE, RI, June 10, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces that it has developed VennVax, a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National...
by Riley Nolan | May 26, 2022 | Featured, Thinking Out Loud -Blog
Monkeypox, Avian Influenza and Q Fever, Oh My! Before getting to other news, we share your sorrow and horror over the lives lost in Texas this week and agree that common sense gun legislation is long overdue in the USA. EpiVax team members are appalled and saddened...
by Riley Nolan | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
by Riley Nolan | Feb 18, 2021 | Featured, Thinking Out Loud -Blog
Zoom Fatigue is REAL! Like you, we’ve been insanely busy with virtual conferences in the last few weeks. We are all REALLY looking forward to meeting in person again. Meanwhile, my Zoom-buddy Jack has become quite the lap(top)-dog! The good news is that...